## Answer
(model generated chain of thought explanation)

Given the patient's history of high-grade non-Hodgkin lymphoma, deep vein thrombosis (DVT), and recent chemotherapy, it is essential to consider medications that could have contributed to his current condition.

Firstly, let's analyze the options provided:

A. Protamine sulfate - This medication is used to reverse the anticoagulant effects of heparin. However, in this case, the patient has been on low molecular weight heparin (LMWH) for five months and only received a subcutaneous dose during chemotherapy. Therefore, protamine sulfate would not have prevented his current condition.

B. Mercaptoethane sulfonate - This is an antifolate medication used to treat certain types of cancer, including lymphoma. It works by inhibiting dihydrofolate reductase (DHFR), which is necessary for DNA synthesis and cell division. Given the patient's recent chemotherapy, mercaptoethane sulfonate could have potentially prevented his current condition.

C. Ciprofloxacin - This antibiotic is used to treat bacterial infections. There is no indication in the provided information that the patient has a bacterial infection or that ciprofloxacin would be effective against his current condition.

D. Dexrazoxane - This medication is used to prevent cardiotoxicity associated with anthracycline chemotherapy agents, such as doxorubicin. While it's true that the patient received chemotherapy 2 weeks ago, there is no indication that dexrazoxane was administered in this case.

Considering these options and the patient's history, mercaptoethane sulfonate (B) appears to be the most likely medication that could have prevented his current condition.

Therefore, the answer is B.